Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 4 | 2021 | 55 | 1.250 |
Why?
|
| Pelvic Neoplasms | 2 | 2019 | 10 | 0.770 |
Why?
|
| Radiation Oncology | 6 | 2023 | 51 | 0.760 |
Why?
|
| Radiotherapy | 2 | 2019 | 62 | 0.760 |
Why?
|
| Film Dosimetry | 2 | 2014 | 9 | 0.680 |
Why?
|
| Tissue Expansion Devices | 2 | 2014 | 17 | 0.670 |
Why?
|
| Patient Positioning | 1 | 2019 | 44 | 0.650 |
Why?
|
| Exercise Therapy | 1 | 2019 | 99 | 0.620 |
Why?
|
| Sacrum | 1 | 2018 | 24 | 0.590 |
Why?
|
| Quality Assurance, Health Care | 5 | 2021 | 251 | 0.490 |
Why?
|
| Clinical Trials as Topic | 3 | 2023 | 441 | 0.400 |
Why?
|
| Neoplasms | 5 | 2021 | 1240 | 0.360 |
Why?
|
| Breast Neoplasms | 4 | 2015 | 1118 | 0.350 |
Why?
|
| Developing Countries | 2 | 2017 | 85 | 0.260 |
Why?
|
| Radiotherapy Dosage | 4 | 2023 | 81 | 0.230 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2004 | 3 | 0.220 |
Why?
|
| Clinical Protocols | 2 | 2018 | 135 | 0.220 |
Why?
|
| Metals | 1 | 2004 | 62 | 0.220 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2023 | 27 | 0.220 |
Why?
|
| Sarcoma | 1 | 2023 | 37 | 0.210 |
Why?
|
| Neoplasms, Second Primary | 1 | 2023 | 43 | 0.210 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2023 | 38 | 0.210 |
Why?
|
| Cancer Survivors | 1 | 2023 | 79 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5127 | 0.170 |
Why?
|
| Mastectomy | 2 | 2014 | 52 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 582 | 0.160 |
Why?
|
| Pelvis | 1 | 2019 | 58 | 0.160 |
Why?
|
| Phantoms, Imaging | 2 | 2014 | 216 | 0.150 |
Why?
|
| International Cooperation | 1 | 2017 | 84 | 0.140 |
Why?
|
| Female | 8 | 2023 | 30692 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2019 | 914 | 0.130 |
Why?
|
| Humans | 15 | 2023 | 59277 | 0.130 |
Why?
|
| Information Management | 1 | 2015 | 11 | 0.130 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 33 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2015 | 133 | 0.120 |
Why?
|
| Aged | 4 | 2019 | 13410 | 0.120 |
Why?
|
| Global Health | 1 | 2015 | 167 | 0.110 |
Why?
|
| Hodgkin Disease | 2 | 2015 | 55 | 0.110 |
Why?
|
| Mammaplasty | 1 | 2014 | 43 | 0.110 |
Why?
|
| Adult | 4 | 2019 | 15662 | 0.110 |
Why?
|
| Middle Aged | 4 | 2019 | 16309 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 243 | 0.100 |
Why?
|
| Breast | 1 | 2014 | 173 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 325 | 0.100 |
Why?
|
| Male | 4 | 2023 | 27724 | 0.090 |
Why?
|
| Child | 5 | 2023 | 4173 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6070 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 58 | 0.060 |
Why?
|
| Meningioma | 1 | 2023 | 59 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2023 | 57 | 0.050 |
Why?
|
| Adolescent | 3 | 2023 | 5822 | 0.050 |
Why?
|
| Young Adult | 2 | 2023 | 4266 | 0.040 |
Why?
|
| Age Factors | 1 | 2023 | 1504 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1486 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1782 | 0.040 |
Why?
|
| Organizations, Nonprofit | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2015 | 14 | 0.030 |
Why?
|
| Africa | 1 | 2015 | 21 | 0.030 |
Why?
|
| Capacity Building | 1 | 2015 | 21 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 452 | 0.030 |
Why?
|
| Axilla | 1 | 2014 | 15 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2015 | 112 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 102 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 74 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2014 | 38 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 38 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 371 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2014 | 45 | 0.030 |
Why?
|
| Pain Management | 1 | 2015 | 146 | 0.030 |
Why?
|
| Palladium | 1 | 1993 | 4 | 0.030 |
Why?
|
| Radioisotopes | 1 | 1993 | 23 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1993 | 50 | 0.030 |
Why?
|
| Brachytherapy | 1 | 1993 | 38 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2015 | 249 | 0.030 |
Why?
|
| Logistic Models | 1 | 2014 | 1231 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 677 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1988 | 50 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2010 | 290 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 1988 | 147 | 0.020 |
Why?
|
| United States | 1 | 2015 | 7384 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1993 | 24 | 0.010 |
Why?
|
| Mathematics | 1 | 1993 | 32 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 355 | 0.000 |
Why?
|